logo
episode-header-image
Apr 2023
20m 35s

Episode 234: Amar Kishan, MD, on Neoadju...

THE UROMIGOS
About this episode

In the first part of our Hollywood tour, Amar Kishan, MD, joins us to discuss his recent meta-analysis published in the Journal of Clinical Oncology on the effects of concurrent adjuvant sequencing versus neoadjuvant concurrent sequencing. Dr. Kishan also gives an overview of the added benefit that androgen deprivation therapy provides when combined with radiation therapy. Dr. Kishan is the Vice Chair of Clinical and Translational Research and Chief of GU Radiotherapy at the University of California, Los Angeles.


Up next
Nov 24
Episode 442: The History of ARPI Development in Prostate Cancer
<p>Michael Morris from MSKCC joins us for an in-depth review of ARPI development across the spectrum of prostate caner</p> 
51m 12s
Nov 10
Episode 466: #UromigosLive 2025 - Novel Therapy in mRCC
Brian and Tom tag team moderate this session which covers combination data, VEGF/PD1 bispecifics, microbiome approaches, cellular therapy and enrichment strategies. 
53m 3s
Nov 10
Episode 465: #UromigosLive 2025 - Adjuvant Therapy in RCC
Tom leads the panel discussion about this evolving space including the RAMPART data and the press release about pembro/belzu. 
44m 49s
Recommended Episodes
Apr 2023
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.1 Part 1
Dr. Dwight Owen is back on the ASCO Guidelines podcast, discussing the latest updates to the ASCO living guidelines for stage IV NSCLC. In Part 1, Dr. Owen presents the update for stage IV NSCLC without driver alterations. He reviews new evidence from EMPOWER-Lung3 and POSEIDON a ... Show More
11m 24s
Feb 2023
Episode 275: Anti-Racism in Medicine Series – Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction
CPSolvers: Anti-Racism in Medicine Series  Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction Show Notes by Alec Calac February 9, 2022 Summary: This episode highlights racialized disparities in addiction treatment. During ... Show More
1h 21m
Jun 2023
Highlights From the 2023 American Society of Clinical Oncology Annual Meeting
<p>JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting's Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute.<br /> <br /> <strong>Rela ... Show More
21m 41s
Feb 2024
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.3 Part 1
Dr. Jyoti Patel and Dr. Natasha Leighl discuss the latest full update to the stage IV NSCLC without driver alterations living guideline. This guideline addresses first-, second-, and subsequent-line therapy for patients according to their histology (squamous cell and nonsquamous ... Show More
9m 49s
Jul 2021
R-CHOP versus DA-EPOCH-R for Double-Hit Lymphoma
Alan Skarbnik (@ASkarbnik), MD, director of the lymphoma and CLL program, Novant Health (Charlotte, NC), and Aaron Goodman (@AaronGoodman33), MD, hematologist, University of California San Diego, join the show for a long-awaited debate: treating double-hit lymphoma with R-CHOP vs ... Show More
1h 6m
Jan 2022
Journal Review in Surgical Oncology: Perioperative Chemotherapy for Locally Advanced, Resectable, Gastric Cancer
Chemotherapy or surgery first? What is the contemporary management for patients with locally advanced, resectable gastric cancer, and what does the data show? In this episode from the Surgical Oncology team at Behind the Knife, join the discussion on perioperative treatment of lo ... Show More
23m 54s
Jul 2022
Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO Living Guideline (Part 2)
An interview with Dr. Ishmael Jaiyesimi from Beaumont Health Royal Oak and Oakland University William Beaumont School of Medicine in Royal Oak, MI, and Dr. Andrew Robinson from Kingston General Hospital, Queen's University in Ontario, Canada, authors on "Therapy for Stage IV Non- ... Show More
11m 59s